Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study

Muhammad Adrish, Jessica DeMartino, Donna Carstens, Mandy Jackson, Jill Schinkel, Kathleen Wilson, Joseph Tkacz

Open source

DOI: 10.2147/jaa.s568990
Published: 2026-03
Container: Journal of Asthma and Allergy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/jaa.s568990,
  title = {Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study},
  author = {Muhammad Adrish and Jessica DeMartino and Donna Carstens and Mandy Jackson and Jill Schinkel and Kathleen Wilson and Joseph Tkacz},
  year = {2026},
  journal = {Journal of Asthma and Allergy},
  doi = {10.2147/jaa.s568990},
  url = {https://doi.org/10.2147/jaa.s568990}
}

RIS

TY  - JOUR
TI  - Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study
AU  - Muhammad Adrish
AU  - Jessica DeMartino
AU  - Donna Carstens
AU  - Mandy Jackson
AU  - Jill Schinkel
AU  - Kathleen Wilson
AU  - Joseph Tkacz
PY  - 2026
JO  - Journal of Asthma and Allergy
DO  - 10.2147/jaa.s568990
UR  - https://doi.org/10.2147/jaa.s568990
ER  -

APA

Adrish, M., DeMartino, J., Carstens, D., Jackson, M., Schinkel, J., Wilson, K., & Tkacz, J. (2026). Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study. Journal of Asthma and Allergy. https://doi.org/10.2147/jaa.s568990

Source records

crossref · retrieved 2026-09-27T14:27:00.412Z